Adjunct/Affiliate Faculty
Mary Cloud B. Ammons
PhD
Allied Faculty
Research Scientist
marycloud.ammonsanderson@va.gov
Dr. Ammons is currently a Research Scientist at the Boise VA Medical Center and specializes in molecular immunology. Dr. Ammons’ background includes research investigating metabolic drivers of innate immune regulation, host-pathogen interactions, and bacterial biofilm formation. Over the course of her career, she has worked with both private and public sector to better understand the complex biology of non-healing wounds with the long-term goal of developing better diagnostics and therapeutics to improve care of recalcitrant wounds such as diabetic foot ulcers and pressure ulcers. Dr. Ammons received her BA in biology from the University of Colorado – Boulder and her PhD from Montana State University – Bozeman.
Michelle Barcelon
PharmD, BCPS, BCCP
Internal Medicine Pharmacy Clinical Specialist
PGY1 Residency Program Director, Renown Regional Medical Center
PPRA
Bhuvanesh Dave
PhD
Allied Faculty
BPSCI
Office: J212 (JLABS Houston)
Drug Discovery • Cancer Research
The goal of Spanios under the guidance of Dr. Dave is to address the unmet need of model systems in rare cancer research. Cancer is a collection of related diseases in which some of the body’s cells begin to divide uncontrollably and spread into surrounding tissues. There are 200 distinct types of cancers 186 of which are categorized as rare cancers. At any given time, of the total number of people suffering from cancer, half of them are battling some type of rare cancer. Twenty percent of all adult tumors, and all hematologic cancers are rare. All pediatric cancers are rare and second leading cause of death in children in the US. Rare cancers are a leading cause of death globally.
We utilize patient derived organoid model systems and test experimental as well as repositioned drugs using for cancer. We use molecular biology, microscopy, and pathway analysis to decipher our results.
Specific research areas are:
- Drug Discovery (Sarcoma Research)
- Immunocompetent Organoid Development in Rare Cancers.
- Development of 3D models with physiological blood supply.
Robert Mancini
PharmD, BCOP, FHOPA
Oncology Pharmacy Program Coordinator
PGY2 Residency Program Director, St. Luke's Mountain States Tumor Institute
PPRA
Oncology Pharmacy
Stephanie Perez
PhD
Term Assistant Professor of Medical Education
WWAMI School of Medical Education
Human Physiology
Office: 111
Professional Studies Building
Anchorage Campus
Oliver Tao
BPharm, PhD
Allied Faculty
Applications Scientist
SilcsBio LLC Baltimore, MD
Dr. Tao is currently an Applications Scientist in Computer-Aided Drug Design (CADD) at SilcsBio LLC. He has contributed to the development of Grand-Canonical Monte Carlo (GCMC) simulation in the Site Identification by Ligand Competitive Saturation (SILCS) methodology. Dr. Tao has broad interests in computer programming for scientific computation, User Interface (UI) design and development for professional CADD software, and improvement of User Experience (UX) for scientific researchers. He has also collaborated with pharmaceutical and biotech companies on the rational design of small molecule drugs and antibodies.
Dr. Tao received a BS degree in Pharmacy from Xiangtan University, China and completed his Ph.D. in Pharmaceutical Science at Idaho State University College of Pharmacy in 2020.